RENEWED EFFORTS AGAINST DIABETES

Many pharmacists probably already have seen prescriptions for Glucophage (metformin hydrochloride), a new drug developed for patients with noninsulin-dependent diabetes mellitus, or NIDDM.The oral antihyperglycemic, from Bristol-Myers Squibb Co., Princeton, N.J., won Food and Drug Administration approval in the spring and is indicated for some people with NIDDM, either as an adjunct to diet therapy

Many pharmacists probably already have seen prescriptions for Glucophage (metformin hydrochloride), a new drug developed for patients with noninsulin-dependent diabetes mellitus, or NIDDM.

The oral antihyperglycemic, from Bristol-Myers Squibb Co., Princeton, N.J., won Food and Drug Administration approval in the spring and is indicated for some people with NIDDM, either as an adjunct to diet therapy or in conjunction with a sulfonylurea, such as chlorpropamide or glyburide. While Gluc

Register to view the full article